Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GT5W
|
|||
| Drug Name |
Elbasvir
|
|||
| Synonyms |
MK 8742; 632L571YDK; MK8742; Elbasvir [USAN:INN]; MK8742; Elbasvir
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Investigative | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C49H55N9O7
|
|||
| Canonical SMILES |
CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC
|
|||
| InChI |
1S/C49H55N9O7/c1-27(2)41(54-48(61)63-5)45(59)56-20-10-14-37(56)43-50-25-34(52-43)30-17-19-36-32(22-30)23-39-33-18-16-31(24-40(33)65-47(58(36)39)29-12-8-7-9-13-29)35-26-51-44(53-35)38-15-11-21-57(38)46(60)42(28(3)4)55-49(62)64-6/h7-9,12-13,16-19,22-28,37-38,41-42,47H,10-11,14-15,20-21H2,1-6H3,(H,50,52)(H,51,53)(H,54,61)(H,55,62)/t37-,38-,41-,42-,47-/m0/s1
|
|||
| InChIKey |
BVAZQCUMNICBAQ-PZHYSIFUSA-N
|
|||
| CAS Number |
CAS 1370468-36-2
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:132967
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drug Repurposing of Approved Drugs Elbasvir, Ledipasvir, Paritaprevir, Velpatasvir, Antrafenine and Ergotamine for Combating COVID19. April 21, 2020. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.